SEC Insider Transactions from Frank Steven.

Last updated: 2026-03-16 23:00 UTC | Total transactions: 23

Frank Steven has filed 23 insider transactions across 2 companies since March 2024.

Most recent transaction: a option exercise of 71839 shares of PRECIGEN, INC. ($PGEN) on March 13, 2026.

Set Up your own filters →
Transaction Date Company Ticker Insider Name Title Transaction Type Security Shares Price Shares Owned Following Total Shares Outstanding % of Owned % of Outstanding
March 13, 2026 PRECIGEN, INC. $PGEN Frank Steven Director M Common Stock 71839 $0.00 1,226,391.0000 353,824,499 6.22% 0.02%
March 13, 2026 PRECIGEN, INC. $PGEN Frank Steven Director M Restricted Stock Units 71839 $0.00 0.0000 353,824,499 100.00% 0.02%
March 10, 2026 PRECIGEN, INC. $PGEN Frank Steven Director A Option to Purchase Common Stock (Right to Buy) 41073 $0.00 41,073.0000 353,824,499 9999.99% 0.01%
March 10, 2026 PRECIGEN, INC. $PGEN Frank Steven Director A Common Stock 14245 $3.51 1,154,552.0000 353,824,499 1.25% 0.00%
March 10, 2026 PRECIGEN, INC. $PGEN Frank Steven Director A Restricted Stock Units 35612 $0.00 35,612.0000 353,824,499 9999.99% 0.01%
Feb. 27, 2026 BIOCRYST PHARMACEUTICALS INC $BCRX Frank Steven Director A Common Stock 1285 $8.75 18,903.0000 219,885,000 7.29% 0.00%
Nov. 28, 2025 BIOCRYST PHARMACEUTICALS INC $BCRX Frank Steven Director A Common Stock 1566 $7.18 17,618.0000 219,885,000 9.76% 0.00%
Aug. 29, 2025 BIOCRYST PHARMACEUTICALS INC $BCRX Frank Steven Director A Common Stock 1353 $8.31 16,052.0000 206,696,000 9.20% 0.00%
June 12, 2025 BIOCRYST PHARMACEUTICALS INC $BCRX Frank Steven Director A Automatic Stock Option Grant 27181 $0.00 27,181.0000 206,696,000 9999.99% 0.01%
June 12, 2025 BIOCRYST PHARMACEUTICALS INC $BCRX Frank Steven Director A Common Stock 12500 $0.00 14,699.0000 206,696,000 568.44% 0.01%
May 30, 2025 BIOCRYST PHARMACEUTICALS INC $BCRX Frank Steven Director A Common Stock 333 $10.75 2,199.0000 206,696,000 17.85% 0.00%
May 2, 2025 BIOCRYST PHARMACEUTICALS INC $BCRX Frank Steven Director A Common Stock 1866 $0.00 1,866.0000 206,696,000 9999.99% 0.00%
May 2, 2025 BIOCRYST PHARMACEUTICALS INC $BCRX Frank Steven Director A Automatic Stock Option Grant 4079 $0.00 4,079.0000 206,696,000 9999.99% 0.00%
March 13, 2025 PRECIGEN, INC. $PGEN Frank Steven Director A Common Stock 28735 $1.74 1,052,895.0000 294,042,973 2.81% 0.01%
March 13, 2025 PRECIGEN, INC. $PGEN Frank Steven Director A Option to Purchase Common Stock (Right to Buy) 83517 $0.00 83,517.0000 294,042,973 9999.99% 0.03%
March 14, 2025 PRECIGEN, INC. $PGEN Frank Steven Director M Restricted Stock Units 87412 $0.00 0.0000 294,042,973 100.00% 0.03%
March 13, 2025 PRECIGEN, INC. $PGEN Frank Steven Director A Restricted Stock Units 71839 $0.00 71,839.0000 294,042,973 9999.99% 0.02%
March 14, 2025 PRECIGEN, INC. $PGEN Frank Steven Director M Common Stock 87412 $0.00 1,140,307.0000 294,042,973 8.30% 0.03%
March 14, 2024 PRECIGEN, INC. $PGEN Frank Steven Director A Restricted Stock Units 87412 $0.00 87,412.0000 0 9999.99% 0.00%
March 14, 2024 PRECIGEN, INC. $PGEN Frank Steven Director A Option to Purchase Common Stock (Right to Buy) 101626 $0.00 101,626.0000 0 9999.99% 0.00%
March 14, 2024 PRECIGEN, INC. $PGEN Frank Steven Director A Common Stock 34965 $1.43 1,024,160.0000 0 3.53% 0.00%
March 9, 2024 PRECIGEN, INC. $PGEN Frank Steven Director M Common Stock 106837 $0.00 989,195.0000 0 12.11% 0.00%
March 9, 2024 PRECIGEN, INC. $PGEN Frank Steven Director M Restricted Stock Units 106837 $0.00 0.0000 0 100.00% 0.00%